IshidaHOzawaNTachikawaM, et al. Interpretable laboratory-data model for risk stratification of elevated NT-proBNP and its deployment in diagnostic support middleware. Ann Clin Biochem2026; 63: 45632261438009. https://doi.org/10.1177/00045632261438009
2.
TsutsuiHAlbertNMCoatsAJS, et al.Natriuretic peptides: role in the diagnosis and management of heart failure. J Card Fail2023; 29(5): 787–804. https://doi.org/10.1016/j.cardfail.2023.02.009
3.
RaslanIRChuAAustinPC, et al.Low socioeconomic status is associated with reduced access to natriuretic peptide testing in the outpatient setting. CJC Open2025; 7: 390–401. https://doi.org/10.1016/j.cjco.2025.01.002
4.
CollinsGSMoonsKGMDhimanP, et al.TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ2024; 385: e078378. https://doi.org/10.1136/bmj-2023-078378
5.
VaseyBNagendranMCampbellB, et al.Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: decide-AI. Nat Med2022; 28: 924–933. https://doi.org/10.1038/s41591-022-01772-9
